125 related articles for article (PubMed ID: 32364270)
1. Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer.
Cho SL; Lin WC; Chuang CA; Liao WY; Lai CF
Nephrology (Carlton); 2020 Sep; 25(9):730. PubMed ID: 32364270
[No Abstract] [Full Text] [Related]
2. Successful retreatment with erlotinib after erlotinib-related interstitial lung disease.
Turk HM; Adli M; Simsek M; Aliyev A; Besiroglu M
Tumori; 2021 Dec; 107(6):NP84-NP86. PubMed ID: 34082639
[TBL] [Abstract][Full Text] [Related]
3. Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.
Jiang X; Song TT; Hao F
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):548-551. PubMed ID: 34219432
[No Abstract] [Full Text] [Related]
4. Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.
Dong JK; Lei HM; Liang Q; Tang YB; Zhou Y; Wang Y; Zhang S; Li WB; Tong Y; Zhuang G; Zhang L; Chen HZ; Zhu L; Shen Y
Theranostics; 2018; 8(7):1808-1823. PubMed ID: 29556358
[TBL] [Abstract][Full Text] [Related]
5. Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient.
Hecimovic A; Vukic Dugac A; Jankovic Makek M; Cikes M; Samarzija M; Jakopovic M
Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31315351
[TBL] [Abstract][Full Text] [Related]
6. Acute tubulointerstitial nephritis due to large amount of sorrel (Rumex acetosa) intake.
Selçuk SN; Gülhan B; Düzova A; Tekşam Ö
Clin Toxicol (Phila); 2015 Jun; 53(5):497. PubMed ID: 25874577
[No Abstract] [Full Text] [Related]
7. Tubulointerstitial Nephritis in Sjögren Syndrome Treated With Mycophenolate Mofetil.
Koratala A; Reeves WH; Segal MS
J Clin Rheumatol; 2017 Oct; 23(7):402-403. PubMed ID: 28937480
[No Abstract] [Full Text] [Related]
8. Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis.
Fernandez-Juarez G; Perez JV; Caravaca-Fontán F; Quintana L; Shabaka A; Rodriguez E; Gadola L; de Lorenzo A; Cobo MA; Oliet A; Sierra M; Cobelo C; Iglesias E; Blasco M; Galeano C; Cordon A; Oliva J; Praga M;
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1851-1858. PubMed ID: 30397027
[TBL] [Abstract][Full Text] [Related]
9. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
Muriithi AK; Leung N; Valeri AM; Cornell LD; Sethi S; Fidler ME; Nasr SH
Am J Kidney Dis; 2014 Oct; 64(4):558-66. PubMed ID: 24927897
[TBL] [Abstract][Full Text] [Related]
10. Statin-associated acute interstitial nephritis and rhabdomyolysis.
Panchangam V
Saudi J Kidney Dis Transpl; 2014 May; 25(3):659-60. PubMed ID: 24821172
[No Abstract] [Full Text] [Related]
11. Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab.
Taki T; Oda N; Fujioka Y; Mitani R; Tokura T; Takata I; Oshiro Y; Takigawa N
Intern Med; 2020 Jul; 59(13):1639-1642. PubMed ID: 32269191
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
[TBL] [Abstract][Full Text] [Related]
13. Peroral cholangioscopy of nivolumab-related (induced) ulcerative cholangitis in a patient with non-small cell lung cancer.
Kuraoka N; Hara K; Terai S; Yatabe Y; Horio Y
Endoscopy; 2018 Sep; 50(9):E259-E261. PubMed ID: 29969801
[No Abstract] [Full Text] [Related]
14. [Acute, drug-induced tubulointerstitial nephritis].
Schlöndorff D; Segerer S
Internist (Berl); 1996 Nov; 37(11):1084-91. PubMed ID: 9036103
[No Abstract] [Full Text] [Related]
15. Erlotinib-associated bilateral anterior uveitis: resolution with posterior sub-Tenon's triamcinolone without erlotinib cessation.
Kirkpatrick CA; Almeida DR; Hornick AL; Chin EK; Boldt HC
Can J Ophthalmol; 2015 Oct; 50(5):e66-7. PubMed ID: 26455982
[No Abstract] [Full Text] [Related]
16. Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.
Steffens M; Paul T; Hichert V; Scholl C; von Mallek D; Stelzer C; Sörgel F; Reiser B; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kächele V; Seufferlein T; Stingl J
Eur J Cancer; 2016 Mar; 55():131-9. PubMed ID: 26820683
[TBL] [Abstract][Full Text] [Related]
17. EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP).
Ruiz-Patiño A; Castro CD; Ricaurte LM; Cardona AF; Rojas L; Zatarain-Barrón ZL; Wills B; Reguart N; Carranza H; Vargas C; Otero J; Corrales L; Martín C; Archila P; Rodriguez J; Avila J; Bravo M; Pino LE; Rosell R; Arrieta O;
Target Oncol; 2018 Oct; 13(5):621-629. PubMed ID: 30284706
[TBL] [Abstract][Full Text] [Related]
18. Presentation, diagnosis, and treatment outcome of tuberculous-mediated tubulointerstitial nephritis.
Chapagain A; Dobbie H; Sheaff M; Yaqoob MM
Kidney Int; 2011 Mar; 79(6):671-677. PubMed ID: 21160461
[TBL] [Abstract][Full Text] [Related]
19. [A case of Sweet syndrome in a patient receiving erlotinib for lung adenocarcinoma].
Ahangari D; Ngendahayo P; Colinet B; Roquet-Gravy PP
Ann Dermatol Venereol; 2020 Mar; 147(3):202-206. PubMed ID: 32029299
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC).
Faehling M; Achenbach J; Staib P; Steffen U; Tessen HW; Gaillard VE; Brugger W
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1375-1383. PubMed ID: 29687154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
